Radiation therapy induced effects on lymphocyte subpopulations and prognostic value of CD69, PD-1 and PD-L1 in the peripheral blood of patients with advanced HNSCC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Ludwig-Maximilians-Universität, Dissertation, 2021
- Keyword
-
Blood
Radiotherapy
Patients
Value
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2021
- Creator
- Contributor
-
Göbel, Thomas
- DOI
-
10.5282/edoc.28664
- URN
-
urn:nbn:de:bvb:19-286649
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Muggenthaler, Christina Lucia
- Göbel, Thomas
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2021
Other Objects (12)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors